536 related articles for article (PubMed ID: 19891232)
1. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
Shema L; Ore L; Geron R; Kristal B
Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired acute kidney injury in Israel.
Shema L; Ore L; Geron R; Kristal B
Isr Med Assoc J; 2009 May; 11(5):269-74. PubMed ID: 19637503
[TBL] [Abstract][Full Text] [Related]
3. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
4. The incidence of contrast-induced nephropathy in trauma patients.
Hipp A; Desai S; Lopez C; Sinert R
Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
[TBL] [Abstract][Full Text] [Related]
5. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
6. The clinical and renal consequences of contrast-induced nephropathy.
Finn WF
Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
McCullough P
Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of contrast-induced nephropathy.
McCullough PA; Sandberg KR
Rev Cardiovasc Med; 2003; 4 Suppl 5():S3-9. PubMed ID: 14668704
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
[TBL] [Abstract][Full Text] [Related]
10. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
Feldkamp T; Kribben A
Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of contrast-induced nephropathy.
Al-Ghonaim M; Pannu N
Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
[TBL] [Abstract][Full Text] [Related]
12. Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped?
Kulvatunyou N; Rhee PM; Carter SN; Roberts PM; Lees JS; Bender JS; Albrecht RM
Am Surg; 2011 Jun; 77(6):686-9. PubMed ID: 21679633
[TBL] [Abstract][Full Text] [Related]
13. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
Reddan D; Fishman EK
Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
[TBL] [Abstract][Full Text] [Related]
14. [Contrast nephropathy and its prevention].
Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M
Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580
[TBL] [Abstract][Full Text] [Related]
15. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy: what are the true clinical consequences?
Rudnick M; Feldman H
Clin J Am Soc Nephrol; 2008 Jan; 3(1):263-72. PubMed ID: 18178787
[TBL] [Abstract][Full Text] [Related]
17. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
Malhis M; Al-Bitar S; Al-Deen Zaiat K
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
19. Risk for contrast-induced nephropathy in elderly trauma patients.
Finigan R; Pham J; Mendoza R; Lekawa M; Dolich M; Kong A; Bernal N; Lush S; Barrios C
Am Surg; 2012 Oct; 78(10):1114-7. PubMed ID: 23025953
[TBL] [Abstract][Full Text] [Related]
20. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome.
Lakhal K; Ehrmann S; Chaari A; Laissy JP; Régnier B; Wolff M; Pajot O
J Crit Care; 2011 Dec; 26(6):593-9. PubMed ID: 21737245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
